Effect of drug for fetal lung maturation during pregnancy on mothers blood glucose levels and fetal well being
- Conditions
- Health Condition 1: O429- Premature rupture of membranes, unspecified as to length of time between rupture and onset of labor
- Registration Number
- CTRI/2024/06/069376
- Lead Sponsor
- Government medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1 Pregnant women between 26-34 weeks of gestation with threatened preterm labor pains and premature rupture of membranes
2 Antenatal women between 34-39 weeks planned for lower segment cesarean section (LSCS)
1) Pregnant women with pre-existing diabetes and gestational diabetes mellitus.
2) Pregnant women with fetal growth restriction.
3) Patients who require immediate termination of pregnancy or are in established preterm labor.
4) Pregnant women with evidence of infection, where corticosteroid therapy may lead to flare-up of infection.
5) Patients with chronic kidney disease, and pre-existing adrenal and pancreatic dysfunction.
6) Pregnant women who have received tocolysis with beta-mimetic agents.
7) Multifetal gestation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method